• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty.

作者信息

George Michael D, Baker Joshua F, Winthrop Kevin, Curtis Jeffrey R

机构信息

University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (M.D.G.).

University of Pennsylvania Perelman School of Medicine and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania (J.F.B.).

出版信息

Ann Intern Med. 2019 Nov 5;171(9):680. doi: 10.7326/L19-0528.

DOI:10.7326/L19-0528
PMID:31683280
Abstract
摘要

相似文献

1
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty.类风湿关节炎患者接受关节置换术时使用生物制剂和糖皮质激素的风险。
Ann Intern Med. 2019 Nov 5;171(9):680. doi: 10.7326/L19-0528.
2
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty.类风湿关节炎患者接受关节置换术时使用生物制剂和糖皮质激素的风险
Ann Intern Med. 2019 Nov 5;171(9):679-680. doi: 10.7326/L19-0527.
3
Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors.类风湿关节炎患者全髋关节和全膝关节置换术后的 flares：发生率、特征和危险因素。
J Rheumatol. 2018 May;45(5):604-611. doi: 10.3899/jrheum.170366. Epub 2018 Mar 15.
4
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.2017 年美国风湿病学会/美国髋膝关节外科医师学会择期全髋关节或全膝关节置换术患者风湿性疾病抗风湿药物围手术期管理指南。
Arthritis Rheumatol. 2017 Aug;69(8):1538-1551. doi: 10.1002/art.40149. Epub 2017 Jun 16.
5
Low-dose Glucocorticoid Use Does Not Reduce Biologic Use in Early RA, Nor Do Biologics Reduce the Need for Glucocorticoids.低剂量糖皮质激素的使用并不能减少早期类风湿关节炎患者生物制剂的使用，生物制剂也不能减少糖皮质激素的使用需求。
J Rheumatol. 2019 Apr;46(4):331-332. doi: 10.3899/jrheum.181262.
6
Elucidating the Risks and Benefits of Withholding Biologics to Optimize Surgical Outcomes.阐明停用生物制剂以优化手术结果的风险与益处。
Ann Intern Med. 2019 Jun 18;170(12):886-887. doi: 10.7326/M19-1088. Epub 2019 May 21.
7
Too Little Too Late: Effect of Poor Access to Biologics for Patients with Rheumatoid Arthritis.为时已晚且力度不足：类风湿关节炎患者生物制剂可及性差的影响
J Rheumatol. 2017 Dec;44(12):1765-1766. doi: 10.3899/jrheum.171148.
8
Rheumatoid arthritis: Perioperative management of biologics and DMARDs.类风湿关节炎：生物制剂和改善病情抗风湿药的围手术期管理。
Semin Arthritis Rheum. 2015 Jun;44(6):627-32. doi: 10.1016/j.semarthrit.2015.01.008. Epub 2015 Jan 30.
9
Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.类风湿关节炎患者使用生物制剂导致的胃肠道穿孔：对临床医生的启示。
Drug Saf. 2018 Jun;41(6):545-553. doi: 10.1007/s40264-018-0639-1.
10
Rheumatoid arthritis: Missed opportunities in the 2015 ACR guideline for RA treatment.类风湿关节炎：2015年美国风湿病学会类风湿关节炎治疗指南中错失的机会
Nat Rev Rheumatol. 2016 Mar;12(3):135-6. doi: 10.1038/nrrheum.2015.181. Epub 2016 Jan 14.

引用本文的文献

1
Periprosthetic Joint Infection in Patients With Inflammatory Arthritis: Optimal Tests to Differentiate From Flares.炎性关节炎患者的人工关节周围感染：与病情发作相鉴别的最佳检测方法
J Clin Rheumatol. 2024 Dec 1;30(8):309-314. doi: 10.1097/RHU.0000000000002157. Epub 2024 Oct 30.
2
Influence of Inflammatory Bowel Disease on Patients Undergoing Primary Total Joint Arthroplasty: A Systematic Review and Meta-analysis of Cohort Studies.炎症性肠病对接受初次全关节置换术患者的影响：一项队列研究的系统评价和荟萃分析
Orthop J Sports Med. 2023 Nov 6;11(11):23259671231205541. doi: 10.1177/23259671231205541. eCollection 2023 Nov.
3
[Continue or interrupt? Antirheumatic treatment in elective surgery].
[继续还是中断？择期手术中的抗风湿治疗]
Z Rheumatol. 2022 Aug;81(6):492-500. doi: 10.1007/s00393-022-01236-y. Epub 2022 Jul 8.
4
Recalibration and validation of the Charlson Comorbidity Index in acute kidney injury patients underwent continuous renal replacement therapy.在接受连续性肾脏替代治疗的急性肾损伤患者中对查尔森合并症指数进行重新校准和验证。
Kidney Res Clin Pract. 2022 May;41(3):332-341. doi: 10.23876/j.krcp.21.110. Epub 2022 Jan 21.
5
[Perioperative management of treatment of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society of Rheumatology].[炎性风湿性疾病患者治疗的围手术期管理：德国风湿病学会的更新建议]
Z Rheumatol. 2022 Apr;81(3):212-224. doi: 10.1007/s00393-021-01140-x. Epub 2021 Dec 20.
6
Perioperative Glucocorticoids in Patients With Rheumatoid Arthritis Having Total Joint Replacements: Help or Harm?类风湿关节炎患者全关节置换围手术期使用糖皮质激素：有益还是有害？
ACR Open Rheumatol. 2021 Sep;3(9):654-659. doi: 10.1002/acr2.11306. Epub 2021 Jul 20.
7
Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery.免疫抑制与类风湿关节炎患者髋关节骨折、腹盆腔和心脏手术后再入院和死亡的风险。
Ann Rheum Dis. 2020 May;79(5):573-580. doi: 10.1136/annrheumdis-2019-216802. Epub 2020 Mar 24.